Praetego Competitors and Similar CompaniesClear all

Praetego's competitors and similar companies include Enthera Pharmaceuticals, Hua Medicine, Diasome and Antag Therapeutics.

	Praetego Praetego is a preclinical stage pharmaceutical company committed to addressing serious diabetic complications.	Enthera Pharmaceuticals Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication.	Hua Medicine Hua Medicine (华领医药) is a drug development company.	Diasome Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity.	Antag Therapeutics Antag Therapeutics is a preclinical-stage biotechnology company focused on developing therapies for dietary-related metabolic diseases.
Founding Date	Founding Date 2017	Founding Date 2016	Founding Date 2011	Founding Date 2004	Founding Date 2017
Type	Type Private	Type Private	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech diabetes drug development pharma	Tags Healthcare biotech diabetes drug development pharma	Tags Healthcare biotech diabetes drug development pharma	Tags Healthcare biotech diabetes drug development pharma	Tags Healthcare biotech diabetes drug development pharma
Locations	Locations Durham, US HQ	Locations Milan, IT HQ Milan, IT Milan, IT	Locations Shanghai, CN HQ Beijing, CN Wuhan, CN Hong Kong, HK	Locations Cleveland, US HQ	Locations København, DK HQ
Employees	Employees 4	Employees 225% increase	Employees 168	Employees 1515% increase	Employees 20
Financial
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ¥1.6b (FY, 2025)	Gross profit N/A	Gross profit (kr13.1m) (FY, 2021)
Net income	Net income N/A	Net income N/A	Net income ¥1.1b (FY, 2025)	Net income N/A	Net income (kr14.9m) (FY, 2021)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 32.8m (almost 6 years ago)	Latest funding round N/A	Latest funding round $ 30m (almost 9 years ago)	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 32.8m	Total funding raised $ 242.4m	Total funding raised $ 42.9m	Total funding raised N/A

For sources of this data, please see the company profile

View Company Profiles

Enthera Pharmaceuticals

Milan, IT

Employees

22↑ 5% increase

Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication.

View company

Hua Medicine

Shanghai, CN

Employees

168

Hua Medicine (华领医药) is a drug development company.

View company

Diasome

Cleveland, US

Employees

15↑ 15% increase

Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity.